We are live on ! Find out more
EAM

Empery Asset Management Portfolio holdings

AUM $86.5M
This Fund
S&P 500
This Quarter Est. Return
-21.02%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.3M
AUM Growth
-$26.6M
Cap. Flow
-$16.7M
Cap. Flow %
-78.3%
Top 10 Hldgs %
66.69%
Holding
94
New
24
Increased
–
Reduced
32
Closed
17

Top Buys

Rank Stock Value
1
TCBPW
TC BioPharm (Holdings) plc Warrants
TCBPW
+$1.31M
2
SBFM
Sunshine Biopharma
SBFM
+$1.12M
3
BRCC.WS
BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a
BRCC.WS
+$855K
4
VLNS
The Valens Company, Inc. Common Shares
VLNS
+$854K
5
SLNO
Soleno Therapeutics
SLNO
+$484K

Top Sells

Rank Stock Value
1
ISPC icon
iSpecimen
ISPC
+$3.64M
2
OHAA
OPY Acquisition Corp. I Class A Common Stock
OHAA
+$2.96M
3
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$2.43M
4
RNERU
Mount Rainier Acquisition Corp. Unit
RNERU
+$2.03M
5
CCTSU
Cactus Acquisition Corp. 1 Limited Unit
CCTSU
+$2.02M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.67%
2 Healthcare 19.72%
3 Technology 3.09%
4 Consumer Staples 1.98%
5 Energy 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NLSPW
51
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$38K 0.18%
+150,000
New +$53.2K
PXSAW
52
DELISTED
Pyxis Tankers Inc Warrant
PXSAW
$34K 0.16%
+160,000
New +$34.6K
KBNTW
53
DELISTED
Kubient, Inc. Warrant
KBNTW
$34K 0.16%
80,000
– –
NGC.WS
54
DELISTED
Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share
NGC.WS
$34K 0.16%
70,656
-4,342
-6% -$2.85K
BEATW icon
55
Heartbeam Inc Warrant
BEATW
$40.7K
$33K 0.16%
90,000
– –
TMPMW
56
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$33K 0.16%
99,999
– –
BSLKW
57
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$31K 0.15%
126,665
– –
REVBW icon
58
Revelation Biosciences Warrant
REVBW
$30K 0.14%
233,382
-16,618
-7% -$4.24K
RFL icon
59
Rafael Holdings
RFL
$126M
$30K 0.14%
12,151
-68,969
-85% -$236K
HCDIW
60
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIW
$30K 0.14%
115,814
-4,186
-3% -$1.23K
DRMAW
61
DELISTED
Dermata Therapeutics Warrant
DRMAW
$28K 0.13%
175,000
– –
QTEKW
62
DELISTED
QualTek Services Inc. Warrant
QTEKW
$24K 0.11%
41,773
-1,977
-5% -$1.23K
AREBW
63
DELISTED
American Rebel Holdings Warrants
AREBW
$21K 0.1%
+602
New +$22.8K
LMDXW
64
DELISTED
LumiraDx Limited Warrant
LMDXW
$21K 0.1%
23,799
-1,201
-5% -$1.54K
LIXTW
65
DELISTED
Lixte Biotechnology Warrants
LIXTW
$20K 0.09%
+105,263
New +$27K
VLDRW
66
DELISTED
Velodyne Lidar, Inc. Warrants
VLDRW
$20K 0.09%
18,968
-1,032
-5% -$1.07K
SQLLW
67
DELISTED
SeqLL Inc. Warrant
SQLLW
$19K 0.09%
235,000
– –
CCTSW
68
DELISTED
Cactus Acquisition Corp. 1 Limited Warrant
CCTSW
$17K 0.08%
+100,000
New +$41.8K
GSQD.WS
69
DELISTED
G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
GSQD.WS
$16K 0.08%
40,296
-2,477
-6% -$1.28K
ORIAW
70
DELISTED
Orion Biotech Opportunities Corp. Warrant
ORIAW
$15K 0.07%
40,000
– –
BOAS.WS
71
DELISTED
BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share
BOAS.WS
$9K 0.04%
33,332
– –
CLAS.WS
72
DELISTED
Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CLAS.WS
$9K 0.04%
50,000
– –
BCDAW
73
DELISTED
BioCardia, Inc. Warrant
BCDAW
$8K 0.04%
18,459
– –
MDAIW icon
74
Spectral AI Warrants
MDAIW
$5.56M
$7K 0.03%
34,998
– –
MDH.WS
75
DELISTED
MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MDH.WS
$6K 0.03%
37,500
– –
1 2
3
4

Similar funds

BCM
Beaumont Capital Management Boston, Massachusetts $86.4M AUM 20.04% 1-Year Est. Return
TI
Truxt Investmentos Rio De Janeiro, Brazil $86.6M AUM
LCM
LDR Capital Management New York $86.7M AUM 16.32% 1-Year Est. Return
AA
Ascent Advisors Mankato, Minnesota $86.7M AUM
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
CL
CPWA LLC Hood River, Oregon $86.1M AUM
TWM
Tripletail Wealth Management Orlando, Florida $86.9M AUM 39.01% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Empery Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Empery Asset Management held 94 positions worth $21.3M, down 56% from $47.9M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Empery Asset Management withdrew a net $16.7M in Q1 2022, closing 17 positions and reducing 32 holdings. Its most notable exit was iSpecimen, an estimated $3.64M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 46% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Empery Asset Management opened a new position in TC BioPharm (Holdings) plc Warrants worth $1.38M.

  • Empery Asset Management's largest Q1 2022 buy was TC BioPharm (Holdings) plc Warrants: 2,823,528 shares worth $1.38M.
  • Empery Asset Management's biggest Q1 2022 reduction was Starling Oncology, cutting an estimated $872K.
  • Empery Asset Management fully exited iSpecimen in Q1 2022, selling an estimated $3.64M.
  • Empery Asset Management's ten largest holdings make up 67% of its $21.3M portfolio in Q1 2022.
  • Empery Asset Management opened 24 new positions and closed 17 in Q1 2022.
  • Empery Asset Management's portfolio value fell 56% quarter-over-quarter to $21.3M.

Based on Empery Asset Management's 13F filing for Q1 2022, filed 16 May 2022.